What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of Experience

Uterine serous carcinoma accounts for 3–10% of endometrial cancers, but it is the most lethal histopathological subtype. The molecular characterization of endometrial carcinomas has allowed novel therapeutic approaches for these patients. We undertook a retrospective analysis of patients with uterin...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Michalis Liontos, Anna Svarna, Charalampos Theofanakis, Oraianthi Fiste, Angeliki Andrikopoulou, Maria Kaparelou, Konstantinos Koutsoukos, Nikolaos Thomakos, Dimitrios Haidopoulos, Alexandros Rodolakis, Meletios Athanasios Dimopoulos, Flora Zagouri
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	MDPI AG 2021-11-01
سلاسل:	Current Oncology
الموضوعات:	cancer endometrial p53 abnormal expression survival
الوصول للمادة أونلاين:	https://www.mdpi.com/1718-7729/28/6/410
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!